Friedhelm Raue Selected Research

Calcitonin (Calcitonin, Eel)

10/2021	Procalcitonin measured by three different assays is an excellent tumor marker for the follow-up of patients with medullary thyroid carcinoma.
1/2020	[Medullary thyroid carcinoma and multiple endocrine neoplasia type 2].
1/2019	Calcitonin measurement in pediatrics: reference ranges are gender-dependent, validation in medullary thyroid cancer and thyroid diseases.
1/2018	[Recommendation for Calcitonin Screening in Nodular Goiter].
1/2018	Calcitonin Screening in Nodular Goiter-Upper Limits.
9/2017	United States and European Multicenter Prospective Study for the Analytical Performance and Clinical Validation of a Novel Sensitive Fully Automated Immunoassay for Calcitonin.
10/2016	Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.
1/2015	Long-Term Follow-up in Medullary Thyroid Carcinoma.
1/2015	Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma.
1/2015	Medullary Thyroid Carcinoma: Imaging.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Friedhelm Raue Research Topics

Disease

9	Thyroid Neoplasms (Thyroid Cancer) 10/2021 - 10/2003
9	Neoplasms (Cancer) 01/2018 - 10/2003
6	medullary Thyroid cancer 01/2021 - 03/2011
6	Multiple Endocrine Neoplasia Type 2a (MEN 2) 01/2019 - 01/2007
5	Neoplasm Metastasis (Metastasis) 10/2021 - 10/2003
3	Nodular Goiter 01/2020 - 01/2018
3	Hyperparathyroidism 11/2016 - 08/2008
2	Hypoparathyroidism 01/2022 - 12/2011
2	Thyroid Diseases (Thyroid Disease) 01/2019 - 01/2015
2	Hyperplasia 01/2018 - 10/2003
2	type 1 familial Hypocalciuric hypercalcemia 11/2016 - 12/2008
2	Hypercalciuria 01/2014 - 12/2011
2	Hypocalcemia 01/2014 - 10/2010
1	Cushing Syndrome 01/2022
1	Vocal Cord Paralysis 01/2022
1	Residual Neoplasm 10/2021
1	Bone Resorption 01/2020
1	Neoplasm Micrometastasis 01/2019
1	Thyroiditis 01/2018
1	Renal Insufficiency (Renal Failure) 01/2018
1	Insulinoma 01/2017
1	Papillary Thyroid Cancer 10/2016
1	Anaplastic Thyroid Carcinoma 10/2016
1	follicular Thyroid cancer 10/2016
1	Thyroid Nodule (Nodule, Thyroid) 01/2015
1	Lymphatic Metastasis 01/2015
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2015
1	Bartter Syndrome (Syndrome, Bartter) 01/2014
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 03/2013
1	Hereditary Neoplastic Syndromes (Cancer Syndrome, Hereditary) 01/2012
1	Nephrocalcinosis 12/2011
1	Primary Hyperparathyroidism 07/2011
1	Chronic Renal Insufficiency 03/2011
1	Pheochromocytoma 08/2008
1	Exanthema (Rash) 08/2007
1	Nausea 08/2007
1	Vision Disorders (Hemeralopia) 06/2004
1	Tachycardia (Tachyarrhythmias) 06/2004
1	Thyroid Hormone Resistance Syndrome (Thyroid Hormone Resistance) 06/2004

Drug/Important Bio-Agent (IBA)

13	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 10/2021 - 01/2007
6	Calcium-Sensing ReceptorsIBA 11/2016 - 12/2008
5	Tumor Biomarkers (Tumor Markers)IBA 10/2021 - 01/2015
5	CalciumIBA 01/2020 - 12/2011
4	Codon (Codons)IBA 01/2011 - 10/2003
2	ProcalcitoninIBA 10/2021 - 03/2011
2	cabozantinibIBA 01/2021 - 10/2016
2	vandetanib (ZD6474)IBA 01/2021 - 10/2016
2	Vitamin D FDA LinkGeneric 01/2020 - 12/2011
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2016 - 01/2012
2	trans-crotonin (CTN)IBA 01/2015 - 01/2015
2	Carcinoembryonic AntigenIBA 01/2015 - 03/2013
1	Phosphotransferases (Kinase)IBA 01/2022
1	ProcollagenIBA 01/2020
1	OsteocalcinIBA 01/2020
1	glutamyl- lysyl- alanyl- histidyl- aspartyl- glycyl- glycyl- arginineIBA 01/2020
1	Parathyroid Hormone (Parathormone)IBA 01/2020
1	hydroxide ionIBA 01/2020
1	Phosphates (Orthophosphate)IBA 01/2020
1	Proton Pump InhibitorsIBA 01/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2017
1	Sorafenib (BAY 43-9006)FDA Link 10/2016
1	Thyroglobulin FDA Link 10/2016
1	RacivirIBA 10/2016
1	Indicators and Reagents (Reagents)IBA 01/2015
1	SaltsIBA 01/2014
1	Sodium Chloride FDA LinkGeneric 01/2014
1	AXT914IBA 01/2014
1	QuinazolinonesIBA 01/2014
1	ATF936IBA 01/2014
1	Pentagastrin (Peptavlon)FDA Link 03/2011
1	Imatinib Mesylate (Gleevec)FDA Link 08/2007
1	Mutant Proteins (Protein, Mutant)IBA 06/2004
1	Thyroid Hormone Receptors beta (TR beta)IBA 06/2004
1	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 06/2004

Therapy/Procedure

4	Thyroidectomy 01/2019 - 11/2010
4	Therapeutics 10/2016 - 08/2007
1	Parathyroidectomy 01/2022
1	Molecular Targeted Therapy 10/2016
1	Precision Medicine 03/2013